Delayed
Hong Kong S.E.
04:08:34 2024-07-17 am EDT
|
5-day change
|
1st Jan Change
|
1.22
HKD
|
+9.91%
|
|
+10.91%
|
+43.53%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
480.1
|
395.7
|
109.1
|
96.8
|
176.5
|
104.3
|
Enterprise Value (EV)
1 |
572.7
|
482.6
|
127.3
|
202.6
|
-9.581
|
-259.3
|
P/E ratio
|
15.4
x
|
11.5
x
|
24.3
x
|
4.7
x
|
3.29
x
|
2.44
x
|
Yield
|
-
|
-
|
-
|
-
|
3.83%
|
-
|
Capitalization / Revenue
|
0.56
x
|
0.54
x
|
0.18
x
|
0.13
x
|
0.37
x
|
0.17
x
|
EV / Revenue
|
0.67
x
|
0.66
x
|
0.21
x
|
0.27
x
|
-0.02
x
|
-0.42
x
|
EV / EBITDA
|
10.3
x
|
10.5
x
|
13.2
x
|
6.39
x
|
1.51
x
|
-3.49
x
|
EV / FCF
|
-20.4
x
|
377
x
|
0.82
x
|
-5.64
x
|
-0.1
x
|
-1.13
x
|
FCF Yield
|
-4.91%
|
0.27%
|
122%
|
-17.7%
|
-1,043%
|
-88.8%
|
Price to Book
|
0.67
x
|
0.52
x
|
0.14
x
|
0.12
x
|
0.21
x
|
0.12
x
|
Nbr of stocks (in thousands)
|
135,000
|
135,000
|
135,000
|
135,000
|
135,000
|
135,000
|
Reference price
2 |
3.556
|
2.931
|
0.8080
|
0.7170
|
1.307
|
0.7726
|
Announcement Date
|
4/15/19
|
5/11/20
|
4/28/21
|
4/27/22
|
4/28/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
858.8
|
726.6
|
607.1
|
763.2
|
472.5
|
620.1
|
EBITDA
1 |
55.74
|
46.17
|
9.656
|
31.73
|
-6.35
|
74.4
|
EBIT
1 |
48.97
|
40.94
|
3.884
|
26.07
|
-12.12
|
70.88
|
Operating Margin
|
5.7%
|
5.63%
|
0.64%
|
3.42%
|
-2.57%
|
11.43%
|
Earnings before Tax (EBT)
1 |
46.41
|
45.11
|
0.503
|
25.72
|
75.77
|
61.05
|
Net income
1 |
31.24
|
34.29
|
4.489
|
20.61
|
53.6
|
42.71
|
Net margin
|
3.64%
|
4.72%
|
0.74%
|
2.7%
|
11.35%
|
6.89%
|
EPS
2 |
0.2314
|
0.2540
|
0.0333
|
0.1527
|
0.3971
|
0.3163
|
Free Cash Flow
1 |
-28.13
|
1.28
|
155.8
|
-35.89
|
99.92
|
230.4
|
FCF margin
|
-3.27%
|
0.18%
|
25.67%
|
-4.7%
|
21.15%
|
37.15%
|
FCF Conversion (EBITDA)
|
-
|
2.77%
|
1,613.63%
|
-
|
-
|
309.61%
|
FCF Conversion (Net income)
|
-
|
3.73%
|
3,470.98%
|
-
|
186.4%
|
539.39%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
0.0500
|
-
|
Announcement Date
|
4/15/19
|
5/11/20
|
4/28/21
|
4/27/22
|
4/28/23
|
4/26/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
92.6
|
86.9
|
18.3
|
106
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
186
|
364
|
Leverage (Debt/EBITDA)
|
1.661
x
|
1.882
x
|
1.891
x
|
3.334
x
|
-
|
-
|
Free Cash Flow
1 |
-28.1
|
1.28
|
156
|
-35.9
|
99.9
|
230
|
ROE (net income / shareholders' equity)
|
4.43%
|
4.64%
|
0.59%
|
2.68%
|
6.64%
|
5.01%
|
ROA (Net income/ Total Assets)
|
1.95%
|
1.65%
|
0.16%
|
1.05%
|
-0.48%
|
2.66%
|
Assets
1 |
1,604
|
2,079
|
2,867
|
1,954
|
-11,055
|
1,606
|
Book Value Per Share
2 |
5.340
|
5.600
|
5.630
|
5.780
|
6.180
|
6.450
|
Cash Flow per Share
2 |
0.1200
|
0.2900
|
0.7700
|
0.0700
|
1.790
|
3.360
|
Capex
1 |
1.48
|
1.1
|
0.69
|
19.7
|
5.53
|
40.6
|
Capex / Sales
|
0.17%
|
0.15%
|
0.11%
|
2.58%
|
1.17%
|
6.55%
|
Announcement Date
|
4/15/19
|
5/11/20
|
4/28/21
|
4/27/22
|
4/28/23
|
4/26/24
|
|
1st Jan change
|
Capi.
|
---|
| +43.53% | 19.19M | | +29.11% | 2.24B | | -0.86% | 1.17B | | +45.71% | 1.08B | | +14.62% | 948M | | +23.12% | 742M | | +2.05% | 600M | | +6.63% | 540M | | -28.53% | 516M | | -26.52% | 454M |
Purification & Treatment Equipment
|